浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:周天華

發(fā)布時(shí)間:2021-10-07 編輯:考研派小莉 推薦訪問(wèn):
浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:周天華

浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:周天華內(nèi)容如下,更多考研資訊請(qǐng)關(guān)注我們網(wǎng)站的更新!敬請(qǐng)收藏本站,或下載我們的考研派APP和考研派微信公眾號(hào)(里面有非常多的免費(fèi)考研資源可以領(lǐng)取,有各種考研問(wèn)題,也可直接加我們網(wǎng)站上的研究生學(xué)姐微信,全程免費(fèi)答疑,助各位考研一臂之力,爭(zhēng)取早日考上理想中的研究生院校。)

浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:周天華 正文


  姓名:周天華
  職務(wù):基礎(chǔ)醫(yī)學(xué)系副主任
  職稱:教授
  學(xué)歷:博士
  專業(yè):細(xì)胞生物學(xué)、病理學(xué)與病理生理學(xué)
  所屬院系:基礎(chǔ)醫(yī)學(xué)系

  研究方向:
  分子細(xì)胞生物學(xué)、胃腸腫瘤學(xué)

  個(gè)人簡(jiǎn)介
  周天華,男,1970年出生,博士,教授,博士生導(dǎo)師,“教育部新世紀(jì)優(yōu)秀人才計(jì)劃”獲得者。
  1993年獲浙江大學(xué)醫(yī)學(xué)院臨床醫(yī)學(xué)學(xué)士學(xué)位,1996年獲浙江大學(xué)醫(yī)學(xué)院臨床醫(yī)學(xué)碩士學(xué)位,1999年獲中國(guó)科學(xué)院上海生命科學(xué)院生物化學(xué)和細(xì)胞生物學(xué)研究所理學(xué)博士學(xué)位。
  2000年赴美國(guó)哈佛大學(xué)分子細(xì)胞生物學(xué)系進(jìn)行博士后訓(xùn)練,于2005年回國(guó)在浙江大學(xué)醫(yī)學(xué)院任教,現(xiàn)任浙江大學(xué)基礎(chǔ)醫(yī)學(xué)系副主任。
  周天華博士在分子細(xì)胞生物學(xué)和分子腫瘤學(xué)等領(lǐng)域,具有比較扎實(shí)的理論知識(shí)和實(shí)踐基礎(chǔ),自1997年以來(lái),已在《Dev Cell》(Cell 子刊)、《PNAS》(美國(guó)國(guó)家科學(xué)院院刊)和《J Biol Chem》等國(guó)際學(xué)術(shù)期刊 發(fā)表了29篇原始學(xué)術(shù)論文,合計(jì)影響因子超過(guò)140,受到國(guó)際同行們的關(guān)注(已被國(guó)際學(xué)術(shù)雜志引用了數(shù)百次)。國(guó)際權(quán)威雜志Nature Reviews Molecular Cell Biology曾經(jīng)以新聞的方式報(bào)道過(guò)其工作,由世界知名生物醫(yī)學(xué)科學(xué)家組成的獨(dú)立同行評(píng)議服務(wù)機(jī)構(gòu)Faculty of 1000,也專門(mén)推薦其研究成果。
  2009年起,其領(lǐng)導(dǎo)的研究小組在細(xì)胞運(yùn)動(dòng)分子機(jī)理調(diào)控及人類重大疾病發(fā)生發(fā)展的細(xì)胞運(yùn)動(dòng)基礎(chǔ)等領(lǐng)域,取得了一些有價(jià)值的實(shí)驗(yàn)結(jié)果,在《PNAS》和《J Biol Chem》等國(guó)際著名刊物上發(fā)表了一系列的原創(chuàng)性學(xué)術(shù)文章。其研究工作受到國(guó)家自然科學(xué)基金、國(guó)家高技術(shù)研究發(fā)展計(jì)劃(863計(jì)劃)、國(guó)家重點(diǎn)基礎(chǔ)研究發(fā)展計(jì)劃(973計(jì)劃)等項(xiàng)目的資助。

  主要學(xué)術(shù)兼職:
  中國(guó)細(xì)胞生物學(xué)學(xué)會(huì)精細(xì)細(xì)胞結(jié)構(gòu)與功能分會(huì) 秘書(shū)長(zhǎng)
  浙江省細(xì)胞生物學(xué)學(xué)會(huì) 常務(wù)理事
  Cell Research (影響因子9.417)編委

  近年來(lái)發(fā)表主要原始論文:
  作為通訊作者和第一作者的主要論文(* 通訊作者):
  1.Xu Y, Deng Y, Yan X and Zhou T*.Targeting miR-375 in gastric cancer.Expert Opinion on Therapeutic Targets.(doi:10.1517/14728222.2011.581232) May 2011.(最新影響因子: 3.649)
  2.Zhu X, Liu X, Jin Q, Cai Y, Yang Y and Zhou T.* (2010).The L279P Mutation of Nuclear Distribution Gene C (NudC) Influences Its Chaperone Activity and LIS1 Stability.Journal of Biological Chemistry 285(39):29903-29910.(最新影響因子: 5.328)
  3.Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, Hao H, Liu X, Si J and Zhou T.* (2010).MiR-375 Frequently Down-regulated in Gastric Cancer Inhibits Cell Proliferation by Targeting JAK2.Cell Research 20(7):784-793.(最新影響因子: 9.417)
  4.Yang Y, Yan X, Cai Y, Lu Y, Si J* and Zhou, T.* (2010).NudC-like protein 2 regulates the LIS1/dynein pathway by stabilizing LIS1 with Hsp90.Proceedings of the National Academy of Sciences of the United States of America 107(8): 3499-3504.(最新影響因子: 9.771)
  5.Cai Y, Yang Y, Shen M and Zhou T.* (2009) Inhibition of cytokinesis by overexpression of NudCL that is localized to the centrosome and midbody.Cell Research 19(11):1305-1308.(當(dāng)年影響因子: 8.151)
  6.Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T* and Si M.* (2009) Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.Journal of Gastroenterology 44(6):556–561.(當(dāng)年影響因子: 2.909)
  7.Zhou T, Zimmerman W, Liu X and Erikson RL.(2006).A Mammalian NudC-Like Protein Essential for Dynein Stability and Cell Viability.Proceedings of the National Academy of Sciences of the United States of America 103(24):9039-9044.(當(dāng)年影響因子: 9.643)
  8.Zhou T,* Aumais J, Liu X, Yu-Lee, LY and Erikson, RL.(2003).A role for Plk1 phosphorylation of NudC in cytokinesis.Developmental Cell 5(1):127-138.(當(dāng)年影響因子: 14.807)
  9.Zhou TH, Ling K, Guo J, Zhou H, Wu Y, Jing Q, Ma L and Pei G.(2000).Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase.Journal of Biological Chemistry 275(4):2513-2519.(當(dāng)年影響因子: 7.368)
  10.Wu GX,# Lin YM, # Zhou TH, # Gao H and Pei G.(2000).Significant down-regulation of alpha-albumin in human hepatoma and its implication.Cancer Letters 160(2), 229-236.(#共同第1作者,當(dāng)年影響因子: 1.517)
  11.Zhou TH, Ren XH, Yin DL, Wu YL, Li M, Lu CZ, Wu DC, Wu YQ, Peng YQ, Wang YP, Ma L and Pei G.(1997).Retardation of pain development: a case of recovery from congenital insensitivity to pain.Acta Anaesthesiologica Scandinavica 41, 1077-1079.(當(dāng)年影響因子: 1.953)

  作為合作作者的主要論文:
  12.Gan L, Chen S, Zhong J, Wang X, EK Lam, Liu X, Zhang J, Zhou T, Yu J, Si J, Wang L, and Jin H.(2011).ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer.PloS One 6(2): e16916.(最新影響因子: 4.610)
  13.Zhou Q, Lu X, Gan L, Chen S, Zhou T, Wang L and Si J.(2010).Role of REG Iα in gastric carcinogenesis: Gastrin-associated proliferative and anti-apoptotic activities.Molecular Medicine REPORORTS 3(6):   999-1005.(最新影響因子: 0.307)
  14.Li A, Zhou T, Guo L, Si J.(2010) Collagen type I regulates beta-catenin tyrosine phosphorylation and nuclear translocation to promote migration and proliferation of gastric carcinoma cells.Oncology Reports 23(5):1247-1255.(最新影響因子: 1.686)
  15.Zhao Y, Zhou T, Yao H, Hei F, Wang L and Si M.(2009) A Potential Role of Collagens Expression in Distinguishing between Premalignant and Malignant Lesions in Stomach.The Anatomical Record 292(5):692-700.(當(dāng)年影響因子: 1.490)
  16.Chen Y, Chen Y, Liu WL, Zhou TH, Cai JT, Du Q, Wang LJ, Wu JG and Si JM.(2009).Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.Journal Gastroenterology and Hepatology 24(5):912-919.(當(dāng)年影響因子: 2.317)
  17.Pan H, Sheng JZ, Tang L, Zhu R, Zhou TH and Huang HF.(2008).Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.Fertility & Sterility 90(4):1000-1007.(當(dāng)年影響因子: 4.167)
  18.Li M, Zhou TH, Gao Y, Zhang N and Li JC.(2007).Ultrastructure and estrogen regulation of the lymphatic stomata of ovarian bursa in mice.The Anatomical Record 290(10):1195-1202.(當(dāng)年影響因子: 1.800)
  19.Liu WL, Chen SJ, Chen Y, Sun LM, Zhang W, Zeng YM, Zhou TH and Si JM.(2007).Protective effects of heat shock protein70 induced by geranylgeranylacetone in atrophic gastritis in rats.Acta Pharmacology Sinica 28(7):1001-1006.(當(dāng)年影響因子:1.677)
  20.Liu AX, Jin F, Zhang WW, Zhou TH, Zhou CY, Yao WM, Qian YL and Huang HF.(2006).Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss.Biology of Reproduction 75(3):414-420.(當(dāng)年影響因子:3.498)
  21.Liu X, Lin CY, Lei M, Yan S, Zhou T and Erikson RL.(2005).CCT chaperonin complex is required for the biogenesis of functional Plk1.Molecular and Cellular Biology 25(12):4993-5010.(當(dāng)年影響因子: 7.093)
  22.Liu X, Zhou T, Yan S and Erikson RL.(2004).Molecular interaction of polo-like kinase 1 with mitotic kinesin-like protein CHO1/MKLP-1.Journal of Cell Science 117(15):3233-3246.(當(dāng)年影響因子: 6.910)
  23.Liu X, Yan S, Zhou T, Terada Y and Erikson RL.(2004).The MAP kinase pathway is required for entry into mitosis and cell survival.Oncogene 23(3): 763-776.(當(dāng)年影響因子: 6.318)
  24.Wang P, Wu Y, Zhou TH, Sun Y and Pei G.(2000).Identification of alternative splicing variants of the beta subunit of human Ca (2+)/calmodulin-dependent protein kinase II with different activities.FEBS Letters 475(2):107-110.(當(dāng)年影響因子: 3.440)
  25.Yu QM, Cheng ZJ, Zhou TH, Cen B, Guo SQ and Pei G.(1999).Molecular cloning of human beta arrestin1 cDNA, expression and function study.Acta Biochimica et Biophysica Sinica 31(3):344-346.(最新影響因子: 1.547)
  26.Lou LG, Zhou T, Wang P and Pei, G.(1999).Modulation of Ca2+/Calmodulin-Dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of ? and ? Isoforms.Molecular Pharmacology 55(3):557-563.(最新影響因子: 4.725)
  27.Fan GH, Zhou TH, Zhang WB and Pei G.(1998).Suppression of Phospholipase C blocks Gi-mediated inhibition of adenylyl cyclase activity.European Journal of Pharmacology 341(2), 317-322.(最新影響因子: 2.737)
  28.Yu QM., Cheng ZJ, Zhao J, Zhou TH, Wu YL Ma L and Pei G.(1998).Carboxyl terminal of rhodopsin kinase is required for the phosphorylation of photo-activated rhodopsin.Cell Research 8(4),:303-310.(最新影響因子: 9.417)
  29.Wu Y L, Fan GH, ZhaoJ, Zhou TH, Ma L and Pei, G.(1997).Functional expression of Opioid receptor-like Receptor and its endogenous specific agonist Nociceptin/Orphanin FQ during Mouse embryogenesis.Cell Research 7(2):207-215.(最新影響因子: 9.417)

  英文著作:
  1.Zhou, T.a(chǎn)nd Erikson, R.L.A role of Polo-like kinase 1 phosphorylation of NudC in cytokinesis.In Signal Transduction of Cell Division, T.Miki, ed.(Research Signpost).(2005).
  在美國(guó)基因數(shù)據(jù)庫(kù)(GenBank)登錄的基因:
  FJ215684 (Homo sapiens NudC-like protein 2),
  AF083420 (homo sapiens brain-specific STE20-like protein kinase 3, MST3b),
  AF078803 (homo sapiens calcium/calmodulin-dependent protein kinase 2 beta subunit),
  AF081924 (homo sapiens calcium/calmodulin-dependent protein kinase 2 beta 6 subunit),
  AF140350 (Homo sapiens calcium/calmodulin-dependent protein kinase II beta 7 subunit),
  AF083419 (homo sapiens calcium/calmodulin-dependent protein kinase beta 2 e subunit),
  AF081572 (homo sapiens calcium/calmodulin-dependent protein kinase 2 beta e’ subunit),
  AF091486 (homo sapiens calcium/calmodulin-dependent protein kinase 2 alpha subunit),
  AF084040 (homo sapiens beta-arrestin 1A),
  AF084940 (homo sapiens beta-arrestin 1B),
  AF106941 (homo sapiens beta-arrestin 2).

  相關(guān)獲獎(jiǎng)成果:
  1、胃癌前病變癌變準(zhǔn)確監(jiān)測(cè)和有效阻斷技術(shù)體系的建立(2009年中華醫(yī)學(xué)科技獎(jiǎng)、排名第三)

  相關(guān)專利:
  1.美國(guó)專利“Method for detecting liver cell in peripheral blood” (專利證書(shū)號(hào):CN1331417-A,排名第三)

以上老師的信息來(lái)源于學(xué)校網(wǎng)站,如有更新或錯(cuò)誤,請(qǐng)聯(lián)系我們進(jìn)行更新或刪除,聯(lián)系方式

添加浙江大學(xué)學(xué)姐微信,或微信搜索公眾號(hào)“考研派小站”,關(guān)注[考研派小站]微信公眾號(hào),在考研派小站微信號(hào)輸入[浙江大學(xué)考研分?jǐn)?shù)線、浙江大學(xué)報(bào)錄比、浙江大學(xué)考研群、浙江大學(xué)學(xué)姐微信、浙江大學(xué)考研真題、浙江大學(xué)專業(yè)目錄、浙江大學(xué)排名、浙江大學(xué)保研、浙江大學(xué)公眾號(hào)、浙江大學(xué)研究生招生)]即可在手機(jī)上查看相對(duì)應(yīng)浙江大學(xué)考研信息或資源。

浙江大學(xué)考研公眾號(hào) 考研派小站公眾號(hào)
浙江大學(xué)

本文來(lái)源:http://www.qiang-kai.com/zhejiangdaxue/daoshi_481294.html

推薦閱讀